(CL) Colgate-Palmolive - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1941621039
CL: Oral Care, Personal Care, Home Care, Pet Food
Colgate-Palmolive Company (NYSE:CL) is a global consumer goods powerhouse with a diverse portfolio of products spanning oral care, personal care, home care, and pet nutrition. Founded in 1806 and headquartered in New York, the company operates through two primary segments: Oral, Personal and Home Care, and Pet Nutrition. Its Oral, Personal and Home Care segment dominates the global oral care market, offering a wide range of products including toothpaste, toothbrushes, mouthwash, and skin health products under iconic brands like Colgate, Palmolive, and Toms of Maine. The segment also includes personal care items such as shampoos, conditioners, and deodorants, as well as home care products like dishwashing detergents and household cleaners. These products are distributed through traditional retail channels, eCommerce platforms, and professional networks like dentists and skin health specialists.
The companys Pet Nutrition segment is anchored by the Hills Science Diet and Hills Prescription Diet brands, which specialize in premium pet nutrition products. Hills Science Diet offers everyday pet food, while Hills Prescription Diet provides therapeutic nutrition solutions, both distributed through veterinarians, pet supply retailers, and eCommerce platforms. Colgate-Palmolives strategic focus on innovation, sustainability, and brand equity has enabled it to maintain a strong market position across its product categories. The companys commitment to research and development, particularly in oral and pet health, underscores its long-term growth strategy.
From a technical perspective, Colgate-Palmolives stock (NYSE:CL) is currently trading at $95.50, above its 20-day and 50-day moving averages of $92.00 and $90.51, respectively. The stocks 200-day moving average is $94.44, indicating a bullish trend. The Average True Range (ATR) of 2.50 reflects moderate volatility. Based on this data, the stock is likely to maintain its upward momentum, with potential resistance near $98.50 and support at $92.00 over the next three months.
Fundamentally, Colgate-Palmolive boasts a market capitalization of $743.44 billion, with a trailing P/E ratio of 26.11 and a forward P/E of 25.84, suggesting investor confidence in its future earnings growth. The companys price-to-sales ratio of 3.70 aligns with industry averages for consumer goods companies. While the P/B ratio of 367.28 appears elevated, it is less relevant for asset-light consumer goods companies. The companys strong brand portfolio, consistent dividend payouts, and global distribution network underpin its fundamental strength.
3-Month Forecast: Based on technical and fundamental analysis, Colgate-Palmolives stock is expected to trade in a range of $92.00 to $98.50 over the next three months. The bullish crossover of the 20-day and 50-day moving averages, combined with its strong earnings outlook, supports a positive near-term outlook. However, macroeconomic factors such as inflation and consumer spending trends could influence the stocks performance during this period.
Additional Sources for CL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CL Stock Overview
Market Cap in USD | 77,710m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1977-01-03 |
CL Stock Ratings
Growth Rating | 32.7 |
Fundamental | 66.6 |
Dividend Rating | 57.7 |
Rel. Strength | -2.7 |
Analysts | 3.74/5 |
Fair Price Momentum | 90.99 USD |
Fair Price DCF | 96.09 USD |
CL Dividends
Dividend Yield 12m | 2.18% |
Yield on Cost 5y | 3.20% |
Annual Growth 5y | 2.50% |
Payout Consistency | 99.6% |
CL Growth Ratios
Growth Correlation 3m | 68.9% |
Growth Correlation 12m | -35.9% |
Growth Correlation 5y | 67% |
CAGR 5y | 7.95% |
CAGR/Max DD 5y | 0.39 |
Sharpe Ratio 12m | 0.28 |
Alpha | 1.73 |
Beta | 0.117 |
Volatility | 25.50% |
Current Volume | 11291.3k |
Average Volume 20d | 5671k |
As of April 25, 2025, the stock is trading at USD 92.70 with a total of 11,291,264 shares traded.
Over the past week, the price has changed by -2.93%, over one month by +2.55%, over three months by +6.07% and over the past year by +6.56%.
Yes, based on ValueRay Fundamental Analyses, Colgate-Palmolive (NYSE:CL) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.57 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CL as of April 2025 is 90.99. This means that CL is currently overvalued and has a potential downside of -1.84%.
Colgate-Palmolive has received a consensus analysts rating of 3.74. Therefor, it is recommend to hold CL.
- Strong Buy: 7
- Buy: 6
- Hold: 8
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, CL Colgate-Palmolive will be worth about 98.3 in April 2026. The stock is currently trading at 92.70. This means that the stock has a potential upside of +6.01%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 97.9 | 5.6% |
Analysts Target Price | 103.1 | 11.2% |
ValueRay Target Price | 98.3 | 6% |